dipropizine: Clinical Trials

8 trials of dipropizine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 3, 2 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Unknown 1, Withdrawn 1
Phase 12Completed 1, Recruiting 1
Phase 21Unknown 1
Phase 41Completed 1

Follow dipropizine: new trials by email Literature Review of dipropizine trials Research Report on dipropizine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults
PBK_M2301 (levodropropizine + Pelargonium sidoides extract), R1_PBK_M2301 (levodropropizine), R2_PBK_M2301 (Pelargonium sidoides extract) - Healthy Volunteers
Phase 1RecruitingPharmbio Korea Co., Ltd.322025-08-272025-09-12
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
Codeine, Levodropropizine, Ivy Leaves Cough Liquid - Upper Resp Tract Infection
Phase 4CompletedPontificia Universidad Catolica de Chile1962025-05-132025-12-03
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases
Furosemide 40 mg, Levodropropizine, Placebo - saline - Dyspnea
Phase 2 / Phase 3UnknownUniversity Hospital Hradec Kralove1022024-02-272024-04-16
Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Levotuss - Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
Phase 3CompletedHyundai Pharm2722017-01-012018-11-20
Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough
Levopront® syrup 30 mg/5 ml, Libexin® - Cough
Phase 3CompletedDompé Farmaceutici S.p.A1842016-11-092024-04-16
A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
Ambroxol and Levodropropizine, Ambroxol, Levodropropizine - Healthy
Phase 1CompletedHanmi Pharmaceutical Company Limited212012-02-012012-07-19
Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis
diphenhydramine + dropropizine + pseudoephedrine, Dropropizine and fixed dose combination of pseudoephedrine hydrochloride + brompheniramine maleate (Dimetapp® elixir). - Inflammation, Cough
Phase 3WithdrawnAche Laboratorios Farmaceuticos S.A.2011-10-012016-10-19
Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher
Theobromine 300mg, Levodropropizine 10mg - Acute Bronchitis
Phase 3CompletedAhn-Gook Pharmaceuticals Co.,Ltd3322010-05-012011-08-15

Conditions studied

Cough (4)  ·  Bronchitis (1)  ·  Bronchitis, Chronic (1)  ·  Common Cold (1)  ·  Dyspnea (1)  ·  Inflammation (1)  ·  Respiratory Tract Infections (1)  ·  Rhinitis (1)

Sponsors

Ache Laboratorios Farmaceuticos S.A. (1)  ·  Ahn-Gook Pharmaceuticals Co.,Ltd (1)  ·  Dompé Farmaceutici S.p.A (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Hyundai Pharm (1)  ·  Pharmbio Korea Co., Ltd. (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  University Hospital Hradec Kralove (1)

Countries

South Korea (4)  ·  Chile (1)  ·  Czechia (1)  ·  Russia (1)

Top investigators

Federico Saibene, MD (1)  ·  Jae Yeol Kim, M.D. (1)  ·  Ki-Suck Jung, M.D. (1)  ·  Kwan Ho Lee, M.D. (1)  ·  Soo-Taek Uh, M.D. (1)  ·  Sung Soon Lee, M.D. (1)  ·  Vladimir Koblizek, PhD (1)  ·  Wooseong Huh, MD (1)  ·  Yong Bum Park, M.D. (1)  ·  Young Kyoon Kim, M.D. (1)

NIH funding

2018 (1)